Clinical Trial Update: Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating topotecan in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED